-
N-(4-(4-(Cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide
-
BD6300671260075-17-998%
-
¥92.05mg
-
5,8-Dihydroxy-2-(1-hydroxy-4-methylpent-3-en-1-yl)naphthalene-1,4-dione
-
BD15108654952-43-199%
-
¥2751.0250mg
-
1-((2,6-Difluorophenyl)sulfonyl)-4-(naphthalen-2-ylsulfonyl)piperazine
-
BD013281251186660-06-997%
-
¥2435.01g
-
N-(4-(4-Hydroxy-4-isobutylpiperidine-1-carbonyl)phenyl)quinoxaline-5-sulfonamide
-
BD6304001628428-01-298+%
-
¥471.010mg
-
6-(3-Aminobenzyl)-4-methyl-2-(methylsulfinyl)-4H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5(6H)-one
-
BD2572001221186-53-398%
-
¥1800.05mg
-
N-Benzyl-N,3-dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazole-6-sulfonamide
-
BD01169686781656-66-498%
-
¥11329.0100mg
-
Sodium Monofluorophosphate
-
BD12608810163-15-295%
-
¥60.0100g
-
8-((1H-Imidazol-4-yl)methylene)-6,8-dihydro-7H-thiazolo[5,4-e]indol-7-one
-
BD01136012608512-97-698+%
-
¥833.010mg
-
(S)-1-(5-((2,3-Dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan-1-one
-
BD014196932245053-57-898%
-
¥1770.050mg
-
1-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)sulfonyl)-4-((3-fluorophenyl)sulfonyl)piperazine
-
BD01127017796092-26-798%
-
¥2397.0100mg
-
Sodium (3S,4R,5R)-6-((hydrogenphosphonato)oxy)-3,4,5-trihydroxy-2-oxohexyl phosphate xhydrate
-
BD12392441012-14-097%
-
¥64.05g
-
PKRA83 hydrochloride hydrate
-
BD0219338198%
-
¥
-
1-(5-((2,3-Dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan-1-one
-
BD018197532622070-93-198%
-
¥
-
N-(3-Chloro-4-fluorophenyl)-7-fluoro-2-oxo-1,2,3,4-tetrahydroquinoline-6-sulfonamide
-
BD013428021346113-84-597%
-
¥
-
PKM2-IN-4
-
BD0231774798%
-
¥
-
PKM2 Activator 5
-
BD7670162098951-67-698+%
-
¥
-
PKR activator 1
-
BD012859712283420-62-098%
-
¥
-
TP-1454
-
BD025082592490276-04-398%
-
¥
-
PKR activator 2
-
BD013091802283422-04-698%
-
¥
-
PKRA83
-
BD015766601233926-87-898%
-
¥